Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo

Carcinogenesis
Francesco TrapassoAlfredo Fusco

Abstract

DEP-1/HPTPeta, a receptor-type protein tyrosine phosphatase, is a candidate tumor suppressor gene because its expression was blocked in rat and human thyroid transformed cells, and its restoration reverted their neoplastic phenotype. In addition, loss of DEP-1/HPTPeta heterozygosity has been described in mammary, lung and colon primary tumors. We now show that DEP-1/HPTPeta is drastically reduced in several cell lines originating from human epithelial pancreatic carcinomas compared with normal pancreatic tissue. We also show that the infection of AsPC1 and PSN1 cells with a recombinant adenovirus carrying r-PTPeta cDNA (the rat homolog of DEP-1/HPTPeta) inhibits their proliferation. Flow cytometric analysis of the infected cells demonstrated that restoration of r-PTPeta activity disrupts their cell cycle and leads to apoptosis. Finally, the growth of PSN1 xenograft tumors was blocked by the intratumoral injection of a recombinant adeno-associated virus carrying r-PTPeta. The data suggest that restoration of DEP-1/HPTPeta expression could be a useful tool for the gene therapy of human pancreatic cancers.

Citations

Mar 25, 2006·Nature Reviews. Cancer·Arne OstmanFrank D Böhmer
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Keiko TakahashiTakamune Takahashi
May 6, 2011·The Journal of Biological Chemistry·Ondrej StepanekTomas Brdicka
Jun 13, 2013·Biochimica Et Biophysica Acta·Caroline E Nunes-XavierRafael Pulido
Aug 23, 2005·Genes, Chromosomes & Cancer·Masamitsu SatoTakashi Kohno
Nov 26, 2010·Brain Pathology·Astrid PetermannFrank-D Böhmer
May 9, 2012·The FEBS Journal·Francesco PaduanoRodolfo Iuliano
Nov 5, 2011·International Journal of Cancer. Journal International Du Cancer·Sally R LambertCharlotte M Proby
May 7, 2016·PloS One·Keiko TakahashiTakamune Takahashi
Nov 12, 2014·PloS One·Keiko TakahashiTakamune Takahashi
Mar 20, 2008·The Biochemical Journal·Nobuo TsuboiTakamune Takahashi
Apr 15, 2019·Cellular and Molecular Life Sciences : CMLS·Mariana Tannús RuckertVanessa Silva Silveira
Jan 28, 2020·American Journal of Physiology. Renal Physiology·Keiko TakahashiTakamune Takahashi
Jan 29, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yoseop KimYoungsoo Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis